What is Doccla?
Founded in 2019 and headquartered in London, United Kingdom, Doccla specializes in remote patient monitoring through wearable medical devices. The company's core technology enables hospitals to predict patient discharge times by tracking individuals outside of traditional clinical settings. This innovative approach aims to alleviate system bottlenecks and improve hospital efficiency, a critical need in modern healthcare delivery. Doccla's solution addresses the growing demand for proactive patient management and resource optimization within healthcare facilities.
How much funding has Doccla raised?
Doccla has raised a total of $66.3M across 3 funding rounds:
Angel/Seed
$3.3M
Series A
$17M
Series B
$46M
Angel/Seed (2021): $3.3M, investors not publicly disclosed
Series A (2022): $17M led by General Catalyst and Speedinvest
Series B (2024): $46M supported by Elaia and Lakestar
Key Investors in Doccla
Elaia
Elaia, associated with Bengelina Hospitality Group, operates a diverse portfolio of restaurants and retail spaces, emphasizing culinary arts and curated goods. Their involvement suggests a potential interest in diversified investments or strategic partnerships beyond their core hospitality focus.
Lakestar
Lakestar is a venture capital firm focused on partnering with visionary tech entrepreneurs across sectors like Deep Tech, Healthcare, and Fintech. They invest from Seed to Growth stages, leveraging their European tech ecosystem connections to support ambitious founders.
General Catalyst
General Catalyst is a venture capital firm that backs transformational business opportunities across multiple sectors and stages. They provide capital and operational support to entrepreneurs aiming to reshape their industries, with a focus on technology and healthcare.
What's next for Doccla?
The substantial enterprise-level funding, particularly the recent strategic investment, positions Doccla for accelerated growth and market penetration. This capital will likely fuel further development of its remote monitoring technology, expansion into new healthcare markets, and enhancement of its predictive analytics capabilities. The company's focus on alleviating hospital bottlenecks suggests a strategic direction towards becoming an indispensable partner for healthcare systems seeking to optimize patient flow and resource allocation. Future endeavors may include strategic partnerships with larger healthcare providers and further integration of AI for enhanced predictive accuracy.
See full Doccla company page
